BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $393 | -27.4% | 10,412 | -12.3% | 0.01% | -30.0% |
Q2 2023 | $541 | +12.2% | 11,875 | 0.0% | 0.02% | +11.1% |
Q1 2023 | $482 | -63.9% | 11,875 | -54.6% | 0.02% | -63.3% |
Q4 2022 | $1,334 | -99.8% | 26,181 | +120.7% | 0.05% | +104.2% |
Q3 2022 | $639,000 | -37.7% | 11,861 | -25.8% | 0.02% | -36.8% |
Q2 2022 | $1,026,000 | +8.5% | 15,975 | +30.9% | 0.04% | +18.8% |
Q1 2022 | $946,000 | +35.0% | 12,206 | +49.4% | 0.03% | +28.0% |
Q4 2021 | $701,000 | -9.5% | 8,171 | -15.2% | 0.02% | -10.7% |
Q3 2021 | $775,000 | -73.2% | 9,638 | -73.2% | 0.03% | -71.4% |
Q2 2021 | $2,895,000 | -8.1% | 35,957 | -3.8% | 0.10% | -16.9% |
Q1 2021 | $3,151,000 | -42.6% | 37,366 | -45.4% | 0.12% | -48.5% |
Q4 2020 | $5,494,000 | -18.3% | 68,468 | -18.1% | 0.23% | -26.4% |
Q3 2020 | $6,726,000 | -7.7% | 83,642 | -1.2% | 0.31% | -17.5% |
Q2 2020 | $7,287,000 | +3.4% | 84,639 | -2.5% | 0.38% | -5.0% |
Q1 2020 | $7,047,000 | +4.0% | 86,791 | +7.2% | 0.40% | +24.8% |
Q4 2019 | $6,773,000 | – | 80,998 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |